Christina Kinch
Chief Corporate Communications Officer
Replay available
Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2025 Earnings Call
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Yvonne Greenstreet
Chief Executive Officer
Tolga Tangular
Chief Commercial Officer
Krish Kulgar
Chief Research and Development Officer
Jeff Fulton
Chief Financial Officer
Salvin Richard
Analyst, Goldman Sachs
Tazeen Ahmad
Analyst, Bank of America
Maureen Raycroft
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Alnylam Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.256 Ladies and gentlemen, and welcome to the Alnylam Pharmaceuticals 00:00:04.256 -- 00:00:09.502 3Q 2025 Earnings Conference Call. At this time, all lines are in the listen-only 00:00:09.502 -- 00:00:13.926 mode. Following the presentation, we will conduct a question and answer session. 00:00:13.926 -- 00:00:18.271 And if at any time during this call you require immediate assistance, please press star 00:00:18.271 -- 00:00:23.037 zero for the operator. Also note that this call is being recorded on Thursday, October 00:00:23.037 -- 00:00:28.122 30th, 2025. And I would like to turn the conference over to management. 00:00:28.122 -- 00:00:30.170 Please go ahead. 00:00:30.170 -- 00:00:34.237 Good morning, I'm Christina Kinch, Chief Corporate Communications Officer at Alnylam. 00:00:34.237 -- 00:00:38.444 With me today are Yvonne Greenstreet, Chief Executive Officer, Tolga Tangular, Chief 00:00:38.444 -- 00:00:43.532 Commercial Officer, Krish Kulgar, Chief Research and Development Officer, and Jeff Fulton, 00:00:43.532 -- 00:00:47.739 Chief Financial Officer. For those of you participating via conference call, the accompanying 00:00:47.739 -- 00:00:52.126 slides can be accessed by going to the events section of the investors page of our website, 00:00:52.126 -- 00:00:54.009 investors.alnylam.com 00:00:54.009 -- 00:00:59.152 slash events. During today's call, as outlined in slide two, Yvonne will offer some introductory 00:00:59.152 -- 00:01:03.958 remarks and provide general context. Tola will provide an update on our global commercial 00:01:03.958 -- 00:01:08.463 progress. Pushka will review pipeline updates and clinical progress, and Jeff will review 00:01:08.463 -- 00:01:12.468 our financials and guidance, followed by a summary of upcom...